comparemela.com

Latest Breaking News On - Sves biosana - Page 1 : comparemela.com

Svas Biosana S p A : The Board of Directors of SVAS Biosana approves the short-form consolidated half-yearly financial statements as at 30 june 2023 -September 27, 2023 at 05:38 am EDT

EBITDA Margin 12.6% Consolidated EBIT: €4.2 million - EBIT Margin 7.7% Consolidated Net Profit: €2.3 million .

Trentino alto adigeSomma vesuvianaEmilia romagnaSan giuseppe vesuvianoUmberto perilloBorsa italianaBanca profiloAndrea efficaceSvas biosanaSves biosanaSvas biosana groupMinistry of healthBormia groupCompanies registerGroup net financial positionDevelopment department

vimarsana © 2020. All Rights Reserved.